Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-1226Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-1550Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-1609Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-3033Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODENONANOATE (CAS# 112-05-0); (M-H)-Peak areaPAK Untreated

Return to search page
  logo